<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Covid-19 vaccine maker Novavax’s stock has declined by about 18% over the past month, compared to the S&P 500 which remains down by about 3% over the same period. While the broader markets have been weak due to the Russian invasion of Ukraine and expected interest rate hikes by the Federal Reserve.
...read full article on Forbes
